Inotiv, Inc. to Report Fiscal 2024 Third Quarter Financial Results and Host Conference Call on Thursday, August 8, 2024
Inotiv, Inc. (NASDAQ: NOTV), a leading contract research organization, has announced it will release its fiscal 2024 third quarter financial results on Thursday, August 8, 2024, after market close. The company will host a conference call at 4:30 p.m. Eastern Time on the same day to discuss the results. Interested parties can participate by dialing 1-800-225-9448 (Domestic) or 1-203-518-9708 (International) with the Conference ID: INOTIV. A live webcast will be available on the company's website, and a replay will be accessible in the Investors section for those unable to attend the live broadcast.
Inotiv, Inc. (NASDAQ: NOTV), un'importante organizzazione di ricerca contrattuale, ha annunciato che pubblicherà i suoi risultati finanziari del terzo trimestre dell'anno fiscale 2024 giovedì, 8 agosto 2024, dopo la chiusura del mercato. L'azienda terrà una chiamata conferenza alle 16:30 ora orientale nello stesso giorno per discutere i risultati. Le parti interessate possono partecipare componendo il numero 1-800-225-9448 (domestico) o 1-203-518-9708 (internazionale) con l'ID della conferenza: INOTIV. Una diretta web sarà disponibile sul sito dell'azienda e una registrazione sarà accessibile nella sezione Investitori per coloro che non possono partecipare alla trasmissione dal vivo.
Inotiv, Inc. (NASDAQ: NOTV), una organización líder en investigación por contrato, ha anunciado que publicará sus resultados financieros del tercer trimestre del año fiscal 2024 el jueves 8 de agosto de 2024, después del cierre del mercado. La compañía llevará a cabo una conferencia a las 4:30 p.m. hora del Este el mismo día para discutir los resultados. Las partes interesadas pueden participar marcando el 1-800-225-9448 (nacional) o 1-203-518-9708 (internacional) con el ID de conferencia: INOTIV. Una transmisión en vivo estará disponible en el sitio web de la empresa, y una repetición será accesible en la sección de Inversores para aquellos que no puedan asistir a la transmisión en vivo.
Inotiv, Inc. (NASDAQ: NOTV), 선도적인 계약 연구 기관이 발표한 바에 따르면, 2024 회계 연도 3분기 재무 결과를 2024년 8월 8일 목요일 시장 마감 후에 발표할 예정입니다. 회사는 같은 날 동부 표준시 오후 4시 30분에 결과를 논의하기 위해 컨퍼런스 콜을 진행할 것입니다. 관심 있는 분들은 1-800-225-9448(국내) 또는 1-203-518-9708(국제)로 전화하여 회의 ID: INOTIV로 참석하실 수 있습니다. 회사 웹사이트에서 생중계가 제공되며, 생중계에 참석할 수 없는 분들을 위해 투자자 섹션에서 재생이 가능합니다.
Inotiv, Inc. (NASDAQ: NOTV), une organisation de recherche contractuelle de premier plan, a annoncé qu'elle publiera ses résultats financiers du troisième trimestre de l'exercice 2024 le jeudi 8 août 2024, après la fermeture du marché. La société organisera une conférence téléphonique à 16h30 heure de l'Est le même jour pour discuter des résultats. Les parties intéressées peuvent participer en composant le 1-800-225-9448 (domestique) ou le 1-203-518-9708 (international) avec l'ID de conférence : INOTIV. Un webinaire en direct sera disponible sur le site de l'entreprise, et un enregistrement sera accessible dans la section Investisseurs pour ceux qui ne peuvent pas assister à la diffusion en direct.
Inotiv, Inc. (NASDAQ: NOTV), eine führende Auftragsforschungsorganisation, hat angekündigt, dass sie ihre finanziellen Ergebnisse für das dritte Quartal des Geschäftsjahres 2024 am Donnerstag, den 8. August 2024, nach Marktschluss bekannt geben wird. Das Unternehmen wird am selben Tag um 16:30 Uhr Eastern Time eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen. Interessierte können teilnehmen, indem sie 1-800-225-9448 (inländisch) oder 1-203-518-9708 (international) anrufen und die Konferenz-ID: INOTIV eingeben. Ein Live-Webcast wird auf der Unternehmenswebsite verfügbar sein, und eine Aufzeichnung wird für diejenigen zugänglich sein, die nicht an der Live-Übertragung teilnehmen können, im Bereich Investoren.
- None.
- None.
WEST LAFAYETTE, Ind., July 25, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that it will issue its financial results for the fiscal 2024 third quarter ended June 30, 2024, on Thursday, August 8, 2024, after the close of the stock market. The Company will host a conference call that same day at 4:30 p.m. Eastern Time to discuss the results.
Interested parties may participate in the call by dialing:
- 1-800-225-9448 (Domestic)
- 1-203-518-9708 (International)
- INOTIV (Conference ID)
The live conference call webcast will be accessible in the Investors section of the Company’s web site and directly via the following link:
https://viavid.webcasts.com/starthere.jsp?ei=1677787&tp_key=b286b1a375
For those who cannot listen to the live broadcast, an online replay will be available in the Investors section of Inotiv’s web site at: https://www.inotivco.com/investors/investor-information/.
About Inotiv
Inotiv, Inc. is a leading contract research organization dedicated to providing nonclinical and analytical drug discovery and development services and research models and related products and services. The Company’s products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development, all while increasing efficiency, improving data, and reducing the cost of taking new drugs to market. Inotiv is committed to supporting discovery and development objectives as well as helping researchers realize the full potential of their critical R&D projects, all while working together to build a healthier and safer world. Further information about Inotiv can be found here: https://www.inotivco.com/.
This release may contain forward-looking statements that are subject to risks and uncertainties including, but not limited to, risks and uncertainties related to the impact of recent events related to non-human primate matters on the Company’s business, operations, results, financial condition, cash flows, and assets, the Company’s ability to comply with covenants under its credit agreement, changes in the market and demand for the Company’s products and services, the development, marketing and sales of products and services, changes in technology, industry and regulatory standards, the timing of acquisitions and the successful closing, integration and business and financial impact thereof, governmental regulations, inspections and investigations, claims and litigation against or involving the Company, its business and/or its industry, the impact of site closures and consolidations, expansion and related efforts, and various other market and operating risks, including those detailed in the Company's filings with the U.S. Securities and Exchange Commission.
| Company Contact | Investor Relations | |
| Inotiv, Inc. | LifeSci Advisors | |
| Beth A. Taylor, Chief Financial Officer | Bob Yedid | |
| (765) 497-8381 | (516) 428-8577 | |
| btaylor@inotivco.com | bob@lifesciadvisors.com |
FAQ
When will Inotiv (NOTV) release its Q3 2024 financial results?
How can investors participate in Inotiv's (NOTV) Q3 2024 earnings call?
Where can I find the webcast for Inotiv's (NOTV) Q3 2024 earnings call?
What is the ticker symbol for Inotiv on NASDAQ?
